PROCORE

ProCore is a biotechnology company developing solutions to improve the quality of life of patients suffering from joint and bone diseases. The company developing cost-effective solutions with a focus on bone and cartilage regeneration, integrating proprietary scaffolds, growth factors, and stem or progenitor cells. ProCore's flagship RegenoGel family is based on proprietary HAProLink technology, a platform technology that links hyaluronic acid to a protein of choice to create a microenvironment... for the body to heal itself via natural, gentle cartilage and bone regeneration. The company’s technology platform includes a variety of biomaterials useful for multiple clinical applications, in particular, hyaluronic acid-based injectable hydrogels; a set of proprietary growth factors with enhanced activity, selectivity, and stability; and protocols for stem and progenitor cell isolation, expansion, and differentiation. ProCore was established in 2008 and is headquartered in Ness Ziona, HaMerkaz, IsraelMore